Toll Free Helpline (India): 1800 1234 070

Rest of World: +91-9810852116

NAAS Rating: 5.03, Impact Factor: RJIF 5.98 | Free Publication Certificate
updates
NAAS Rating: 5.03 new
Vol. 6, Issue 2 (2017)

Strategy to avoid data integrity issues in pharmaceutical industry

Author(s):
Jain Sanjay Kumar
Abstract:
Data integrity is vital for the pharmaceutical industry and organization shall be able to demonstrate the integrity of the data during regulatory audits. Review of various warning letters revealed that there are compromises w.r.t. data integrity and have resulted into serious implications on the organization including import alert and debarment of the employees.
It is always better to proactively prevent issues, such as data integrity failures to occur, than trying to remediate and resolve inspection findings. Compliance excellence makes good business sense.
This document provides the regulatory requirement, graphical summary of the issues in recent past through review of warning letters, suggest the strategy to prevent the data integrity breaches by design, by procedural control and monitoring.
Pages: 110-115  |  783 Views  15 Downloads
How to cite this article:
Jain Sanjay Kumar. Strategy to avoid data integrity issues in pharmaceutical industry. Pharma Innovation 2017;6(2):110-115.
The Pharma Innovation Journal